MedTrace Logo

A Prospective, Longitudinal Study of Endothelial Function in HIV/HCV Coinfected Subjects

NCT02597790 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 87

Last updated 2022-01-20

Study results available
· View outcomes & findings →

Summary

The CTSI-PLACE Study is a study for men and women with HIV/hepatitis C co-infection or HIV only. The study looks at the impact of having hepatitis C virus in addition to HIV on risk for cardiovascular disease. Participants will undergo non-invasive assessment of cardiovascular disease risk through measurements of endothelial function and blood biomarkers at baseline and 1 year (or 4 weeks and 24 weeks after end of HCV treatment for those that undergo HCV treatment during study follow-up).

Conditions

  • HIV
  • Hepatitis C

Sponsors & Collaborators

Principal Investigators

  • Kara W. Chew, M.D., M.S. · University of California, Los Angeles

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2019-01-31
Completion
2020-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02597790 on ClinicalTrials.gov